Quantum BioPharma Statistics

Total Valuation

CSE:QNTM has a market cap or net worth of CAD 25.44 million. The enterprise value is 14.77 million.

Market Cap	25.44M
Enterprise Value	14.77M

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:QNTM has 2.71 million shares outstanding. The number of shares has increased by 86.67% in one year.

Current Share Class	n/a
Shares Outstanding	2.71M
Shares Change (YoY)	+86.67%
Shares Change (QoQ)	+115.92%
Owned by Insiders (%)	13.13%
Owned by Institutions (%)	3.02%
Float	2.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.69
P/TBV Ratio	2.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.72
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.08.

Current Ratio	1.80
Quick Ratio	1.65
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-488.73

Financial Efficiency

Return on equity (ROE) is -127.76% and return on invested capital (ROIC) is -82.28%.

Return on Equity (ROE)	-127.76%
Return on Assets (ROA)	-58.31%
Return on Invested Capital (ROIC)	-82.28%
Return on Capital Employed (ROCE)	-154.56%
Revenue Per Employee	n/a
Profits Per Employee	-1.20M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.71% in the last 52 weeks. The beta is 0.69, so CSE:QNTM's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-75.71%
50-Day Moving Average	8.78
200-Day Moving Average	7.68
Relative Strength Index (RSI)	50.71
Average Volume (20 Days)	4,731

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.22M
Pretax Income	-21.46M
Net Income	-20.44M
EBITDA	-22.51M
EBIT	-23.22M
Earnings Per Share (EPS)	-17.97

Full Income Statement

Balance Sheet

The company has 10.36 million in cash and 1.19 million in debt, giving a net cash position of 9.17 million or 3.39 per share.

Cash & Cash Equivalents	10.36M
Total Debt	1.19M
Net Cash	9.17M
Net Cash Per Share	3.39
Equity (Book Value)	15.02M
Book Value Per Share	7.18
Working Capital	7.73M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.89M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:QNTM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-86.67%
Shareholder Yield	-86.67%
Earnings Yield	-80.33%
FCF Yield	n/a

Stock Splits

The last stock split was on August 15, 2024. It was a reverse split with a ratio of 0.0153846154.

Last Split Date	Aug 15, 2024
Split Type	Reverse
Split Ratio	0.0153846154

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a